HSP90B2P and chronic obstructive pulmonary disease: Although Hsp level variation has been described as clinically and biochemically relevant (Jain et al., 2014; Hodge et al., 2016), the effects of genetic variation on the expression of the proteins or the susceptibility to COPD secondary to tobacco smoke or BBS remain unclear.